For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study ...

Scientists at NYU Langone discovered that blocking a key protein that shields cancer cells from a natural stress-driven death process can dramatically slow lung tumor growth.

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

Lung cancer stands as a formidable health challenge, claiming more lives globally than any other type of cancer. This ...

Small cell lung cancer cells that metastasize to the brain cozy up to neurons and form working electrical connections, called synapses, according to an upcoming study led by Stanford Medicine ...

LOS ANGELES, April 18 (Reuters) - Testing lung cancer patients for tumor markers would enable doctors to choose which drug the patient is most likely to respond to, improving the chances for ...

Sequential versus concurrent strategy of immunotherapy and radiotherapy in advanced non-small-cell lung cancer: A territory-wide multicenter study (OCEANUS study). This is an ASCO Meeting Abstract ...

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...

Lung cancer develops when lung cells undergo genetic alterations, such as fusions, deletions, or mutations. These changes cause abnormal growths, typically nodules, which often signal that the cancer ...

Preclinical studies indicate that cavity-resident macrophages in the peritoneal and pleural spaces contribute to ...